The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs.

Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ...

Lotus Pharmaceuticals, a Chinese drug developer, announced that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the ...

Tianyin Pharmaceutical Co., Inc. (TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other ...

This leaflet answers some common questions about GLICLAZIDE MR VIATRIS. It does not contain all the available information Reading this leaflet does not take the place of talking to your doctor, ...

Orlando, FL, June 5, 2004 -- Long-term studies using the oral antidiabetic drug ACTOS® (pioglitazone HCl) alone, and in combination with other oral antidiabetic medications, found that it provided ...